Case Report: Immune checkpoint inhibitor plus chemotherapy benefited an elderly patient with non-small cell lung cancer following EGFR-TKI resistance
{{output}}
Renal metastasis from non-small cell lung cancer (NSCLC) is uncommon. This report describes an elderly patient with EGFR-mutant NSCLC and high PD-L1 expression (TPS 70%). Following six months of targeted therapy, the renal lesion increased in size compared to ... ...
